ArticleJournal of translational medicine2021

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.

Xuejie Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.